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Currently different classes of psychoactive substances are easily available for abuse,
including several hundred novel psychoactive substances (NPS). Some of these
drugs occur naturally in plants and animals or are chemically modified from plant or
animal compounds and have been abused by humans over millennia. Recently, the
occurrence of a new “drug culture” (e.g., psychonauts) who consume a great variety
of NPS with hallucinogenic/psychedelic properties, facilitated the development of a new
“psychedelic trend” toward the consumption of substances contained in some species
of animals (“psychedelic fauna”). The present review aims at providing an overview of
the most commonly abused “psychedelic animals,” by combining a dual search strategy
coming from online psychonauts’ experiences and English literature searches on the
PubMed/Medline Google Scholar databases. A multilingual qualitative assessment on
a range of websites and online resources was performed in order to identify a list of
animals who possess some psychoactive properties and could be abused by humans
for recreational purposes. Several species are implicated (i.e., ants, amphibians, fish).
Routes of administration depend on the animal, substance included, metabolism, toxicity
and individual, social and cultural variability. Online purchase and access are easy through
tourism-related search strategies (“frog trip,” “help of charmer snake,” “religious trip”).
Keywords: psychedelic animals, psychedelics, NPS, novel psychoactive substances, hallucinogens, psychedelic
fauna
INTRODUCTION
Humans have used a range of naturally occurring psychoactive substances to modify their
minds, for recreational/mystic/spiritual/religious/psychedelic purposes, over millennia (1). Many
psychotropic chemicals, widely distributed in plants and animals, were discovered by ancient
hunter-gatherers prior to the Neolithic agricultural revolution (2). Humans have learnt how to
cultivate/modify/exploit these chemicals and pass on this cultural knowledge to others (1–3).
Most commonly abused natural drugs and, nowadays, novel psychoactive substances (NPS), cause
changes in brain systems that alter consciousness or affect moods/emotions in some way (1–6).
Moreover, ritualistic/spiritual use of these psychoactive substances has a long history among ancient
tribes/shamanic communities (7–9), by suggesting some evolutionary benefits (mainly in terms of
an increased chance in the survival of a species) related to the historical spread of plant- and/or
animal-derived compounds possessing psychoactive properties, mostly entheogens/hallucinogens
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(3, 10, 11). For example, many psychotropic substances
originally were taken by humans due to their bactericidal and/or
antiparasitic effects (12). Within this context, some psychoactive
compounds have been progressively taken by humans, despite
some toxicological effects, as their intake might determine some
evolutionary benefit, in terms of increasing the survival of a
species and, then, increasing the reproducibility rate (1–6).
Moreover, some psychoactive substances, naturally occurring
in “fauna,” used for ritualistic and religious purposes over the
millennia, could be taken by humans, even though they may have
some toxicological effect, as the advantages in taking them would
exceed the disadvantages, from an evolutionary perspective.
Therefore, the spread of these psychoactive substances, naturally
occurring in “fauna,” may be facilitated by some “cultural”
processes. In fact, some drugs come with a “cultural reputation”
for giving pleasure or relief of physical or emotional pain (13).
Subsequently, in the light of the recent NPS phenomenon,
the “reputation” of these recreational drugs in animals has
also been amplified by the virtual dissemination through the
Internet and social networks (3, 5, 11, 14). Moreover, the current
generation of drug users (i.e., psychonauts) belong to a new
sub-culture, which seems to resemble more to the shamanic
communities (3, 15), by specifically possessing an “attractiveness”
toward such entheogens/psychedelic/hallucinogenic
substances, also included in some animals and/or parts of
them.
Despite many psychoactive substances/NPS have been easily
found in plant sources (11), a variety of animal sources of
psychoactive substances appear to be equally abused, potent and
risky. The term “psychoactive fauna” comes from the Greek
noun psuchè (“life breath,” “spirit,” “soul,” “mind”), the Latin
adjective activus (“active”), and Fauna, the name of the Roman
goddess of fertility (16). “Psychoactive fauna” is currently used
to denote the group of animals whose body parts or excretions
contain one or more substances which, in a sufficiently high
dose, have the potential to alter the user’s state of consciousness
(17). These compounds, naturally occurring in “fauna,” may be
as well considered NPS, as the “novelty,” as previously defined,
does not necessarily mean “new” psychoactive compounds, but
all individual drugs in pure form or in complex preparations that
are not yet scheduled under the Single Convention on Narcotic
Drugs (1961) or the Convention on Psychotropic Substances
(1971) (5).
As the recent spread and interest toward the “natural” NPS
by the psychonauts’ community, the present mini-review aims
at providing an overview of the presence of some substances
with psychoactive/psychedelic properties in fauna, by identifying
their potential human abuse/misuse, their pharmacological and
clinical effects on humans, in order to better qualify another
category of NPS.
MATERIALS AND METHODS
A mini-review was carried out by using the PubMed/Medline
and Google Scholar databases. However, given the limitation of
peer-reviewed data published so far, a preliminary nonparticipant
multilingual qualitative study of a list of prodrug websites and
other online resources (i.e., e-newsgroups, chat-rooms, bulletin
boards, and e-newsletters) was conducted in order to obtain
a list of potentially representatives of the “psychedelic fauna.”
A systematic Internet search was conducted on Duckduckgo R©
and Google R© which included the following keywords: “animal’s
name” and/or possible acronyms, street names etc. plus “to buy,”
“experience,” “trip,” “legal high,” “psychedelic,” “hallucinogen,”
“psychoactive.” The first 5 pages recorded per search term and
search engine were consequently analyzed and selected only if
relevant in terms of information and data provided regarding
to the “psychedelic fauna.” Within the time frame January–July
2017, data were collected from 12 unique prodrug websites.
Confidentiality measures applied to the dataset included storage
in an online, password-protected computer and removal of
screen pseudonyms, URLs, country and city identifiers. Some
2,900 fora threads were screened. After removal of those Web
pages, which were either duplicates or non-relevant to the
aims of the study, 268 fora threads, were analyzed and used
to identify four main species implicated. Ethical approval for
the study has been sought and granted by the Department of
Pharmacy Ethics Committee at the University of Hertfordshire
(December 15, 2010, reference code PHAEC/10-42), with
a further extension of the approval granted in November
2013.
Then, we combined the search strategy of free text
terms and exploded MESH headings for the topics of
Psychedelic Fauna and Novel Psychoactive Substances as
following: ((((Psychedelic OR hallucinogenic OR psychoactive)
substances) [Title/Abstract]) AND ((various name of Animals)
[Title/Abstract]))), as previously identified with the above-
mentioned online search. Secondary searches were performed
using the reference list of included articles and relevant
systematic reviews. All articles published in English without
time restriction were selected. Studies published through to 15
September 2017 were included.We considered studies describing
some psychoactive/psychedelic/hallucinogenic effects following
the intake of some animals (or parts of them), through different
routes of administration, by humans. Working independently
and in duplicate, two reviewers (LO andMC) read the papers and
determined whether they provided data on psychedelic fauna. To
be included in the present review, studies were required to meet
the following criteria: (a) empirical and peer-reviewed study; (b)
at least an abstract with estimates and/or full results published in
English; (c) investigate psychoactive/psychedelic/hallucinogenic
properties of some animals. Studies evaluating the intake
of psychedelics/hallucinogens/other psychoactive substances by
animals were properly excluded as not pertinent with the aims
of the present paper. Moreover, studies mainly focused on
intoxications rather than psychedelic experiences following the
intake of some animals were also excluded from this review.
As non-systematic review, reviews, letters to editors and meta-
analyses were as well considered for retrieving data. LO and
MC, independently extracted the data. Disagreements were
resolved by discussion and consensus with a third member of
the team (DP). Data were collected using an ad-hoc developed
data extraction spreadsheet. The present comprehensive review
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TABLE 1 | Summary of results.
Species Origin Psychopharmacological effects References
HALLUCINOGENIC FISH
a) Clown fish and damselfish (sp. Abudefduf
septemfasciatus; commonly called “Banded
sergeant”)
b) Rabbitfish (sp. Siganus argenteus; sp.
Siganus corallinus; sp. Siganus luridus; sp.
Siganus rivulatus; sp. Siganus spinus)
c) Sea bream (sp. Sarpa salpa, commonly
called ‘Salema’)
d) Sea chub (sp. Kyphosus inerascens; sp.
Kyphosus vaigiensis; Kyphosus bigibbus)
e) Surgeon fish (sp. Acanthurus triostegus,
commonly called ‘Convict surgeonfish’)
f) Goatfish (sp. Mulloidichthys flavolineatus; sp.
Upeneus taeniopterus)
g) Mullet (sp. Migil cephalus; sp. Neomyxus
leuciscus)
h) Groupers (sp. Epinephelus corallicola,
commonly called ‘Coral grouper’)
South Africa and Hawaiian and Norfolk
Islands in the Pacific Ocean.
The Sarpa salpa originates from temperate
and tropical areas, from the Atlantic coast
of Africa extending to the Mediterranean
Sea, particularly near to Spanish coasts;
occasionally found around the British
coastline.
Fish contain hallucinogenic substances.
If ingested raw: may induce hallucinatory and
onyroid effects such as vivid/ terrifying auditory and
visual hallucinations, dizziness, loss of equilibrium,
lack of motor coordination and mental depression,
terror and nightmares, itching, burning of the throat,
muscular weakness, rarely abdominal distress.
If orally ingested: “Sarpa salpa” fish may produce
vivid auditory and visual hallucinations.
(18–22)
Sea chubs from the genus Kyphosus,
supposed to be K. Fuscus or more likely
K. Vaigiensis
Norfolk Island, between Australia and New
Zealand
Hallucinations and ‘dreadful nightmares’ (18)
Urolophus jamaicensis species The Caribbean and Colombia Entheogen/intoxicant/inebriating and aphrodisiac
effects originating from stingrays’ venom
(23)
Siganus spinus Waters around Réunion, South Atlantic Psychedelic effects (24)
Mulloides flavolineatus Hawaii Psychedelic effects (24)
Tetraodontidae include puffers, balloon fish,
blowfish, bubble fish, globefish, swellfish,
toadfish, and toadies.
Tropical regions of South America, Africa
and South East Asia
If orally ingested: poisonous puffer fish can cause
a slight numbness of the lips and tongue, followed
by increasing paresthesia in the face and
extremities, sensations of lightness or floating.
Headache, epigastric pain/nausea/diarrhea and/or
vomiting may also occur. Reeling or difficulty in
walking have been reported. The second stage of
intoxication includes increasing paralysis, respiratory
distress, altered speech, dyspnea, cyanosis, and
hypotension. Whilst paralysis increases,
convulsions, mental impairment, cardiac arrhythmia
and death may occur.
(25, 26)
Fugu Japan Stimulant and aphrodisiac effects
If orally ingesting a non-lethal dose (i.e., <8
µg per kg body weight): tingling in the lips, fingers,
and toes, and extremities may occur.
If orally ingesting a lethal dose (i.e., >8 µg per
kg body weight): numbness, anesthesia,
paresthesia, abdominal pain, nausea, and vomiting,
muscle paralysis and respiratory insufficiency may
occur.
(27, 28)
Somniosus microcephalus North Atlantic and Artic Oceans If orally ingested: may cause diarrhea/ vomiting/
hallucinations/ numbness. It may cause a state of
near-death for several days, while the subject
remains conscious.
(29)
Sea sponges such as Smenospongia aurea Caribbean Sea Psychedelic effects (30–32)
(Continued)
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TABLE 1 | Continued
Species Origin Psychopharmacological effects References
Sea sponges such as S. echina Caribbean Sea Psychedelic effects (30–32)
Sea sponges such as erongula rigida Western Atlantic Ocean: Florida, Gulf of
Mexico, and the Caribbean
Psychedelic effects (30–32)
PSYCHEDELIC AMPHIBIANS
Bufo alvarius and Bufo marinus Mesoamerica Used as ritual intoxicants owing to their viscous
milky-white venom that contains bufotenin and
bufotoxin.
If orally ingested: Bufo toad venom can be fatal.
Single deep inhalations of vaporized venom can
produce intense and transient psychoactive effects
mainly auditory and visual hallucinations.
(33)
Bufo marinus North America B. Marinus venom was used as “Zombie’s powder”.
If orally ingested: Bufo toad venom can be fatal.
Single deep inhalations of vaporized venom can
produce intense and transient psychoactive effects
mainly auditory and visual hallucinations.
(34, 35)
B. Alvarius The Sonoran Desert an area of California
across the southern half of Arizona and
South Mexico.
It contains the enzyme O-methyl-transferase, which
converts bufotenin (5-OH-DMT) to the potent
hallucinogen 5-MeO-DMT. The skin also contains
bufotenin analogs.
If orally ingested: Bufo toad venom can be fatal.
Single deep inhalations of vaporized venom can
produce intense and transient psychoactive effects
mainly auditory and visual hallucinations.
(36, 37)
Phillomedusa bicolor The Peruvian and Brazilian Amazon Buccal absorption of opioid peptides scraped
from the skin may induce rapid
pulse/incontinence/vomiting, a state of listlessness
and euphoria.
(37, 38)
PSYCHEDELIC ANTS
Red harvester ants (e.g., Pogonomyrmex
californicus)
South and South Central California Oral ingestion of live ants may cause
hallucinogenic and/or mind-altering effects.
(39, 40)
provides summary of data collected on three main categories
of animals (fish, amphibians and ants), as illustrated in
Table 1.
RESULTS
“Hallucinogenic” Fish
Certain species of fish, particularly coming from South Africa,
in the Hawaiin and Norfolk Islands in the Pacific Ocean, have
been demonstrated to contain hallucinogenic substances which
may give a “fishing trip” like that produced by lysergic acid
diethylamide (LSD) intake (34). Toxic fish species belonging
to eight families have been implicated: (a) Clown fish and
damselfish (sp. Abudefduf septemfasciatus; commonly called
“Banded sergeant”); (b) Rabbitfish (sp. Siganus argenteus; sp.
Siganus corallinus; sp. Siganus luridus; sp. Siganus rivulatus; sp.
Siganus spinus); (c) Sea bream (sp. Sarpa salpa, commonly called
“Salema”); (d) Sea chub (sp. Kyphosus inerascens; sp. Kyphosus
vaigiensis; Kyphosus bigibbus); (e) Surgeon fish (sp. Acanthurus
triostegus, commonly called “Convict surgeonfish”); (f) Goatfish
(sp. Mulloidichthys flavolineatus; sp. Upeneus taeniopterus); (g)
Mullet (sp.Migil cephalus; sp. Neomyxus leuciscus); (h) Groupers
(sp. Epinephelus corallicola, commonly called “Coral grouper”)
(18).
Several hallucinatory and onyroid experiences, also called
“Ichthyoallyeinotoxic or hallucinatory mullet poisoning” or
“ichthyoallyeinotoxism,” have been reported after ingestion of
the above-mentioned fish as raw (19–21). The effects of
eating Ichthyoallyeinotoxic raw fish may include vivid/terrifying
auditory and visual hallucinations, dizziness, loss of equilibrium,
lack of motor coordination and mental depression, terror and
nightmares, itching, burning of the throat, muscular weakness,
rarely abdominal distress (19–21). Symptomatology may occur
within a few minutes to 2 h after consumption, and may last
for up to 24 h (18, 19). The first symptoms usually comprise
imbalance, loss of coordination and a generalized malaise,
followed by delirium, visual and/or auditory hallucinations
(mainly zooptic), depression and nightmares (18, 19, 22, 41).
However, there is no clear evidence of an intentional recreational
use of these toxins for their “dream-inducing” properties, as
most cases have been described occurring due to an accidental
intoxication (18).
The “Sarpa salpa” (aka “salema porgy,” “dream fish” or
“nightmare fish”) may produce vivid auditory and visual
hallucinations if orally ingested (18, 20). Sarpa salpa is easily
recognized by its gold stripes running along its side. It usually
inhabits temperate and tropical areas, from the Atlantic coast
of Africa to the Mediterranean Sea, particularly near to Spanish
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coasts; whilst it is occasionally found around the British coastline
(22). It belongs to the Sparidae family and represents a popular
dish across many Mediterranean countries (22). It may cause
vivid hallucinations in few minutes after ingestion, which may
last for days (18). It originally became a recreational drug during
the Roman Empire in which it was commonly called as “the fish
that makes dreams” in Arabic (18). Anecdotal online trip reports
described that “[. . . ] the subjective effects are evident the next day
after eating, they had vivid nightmares (I like a giant black dog
chasing me through a forest as a kid sometimes after eating some
of these usually just fried whole, after being scaled and gutted on
each side in butter), more lethargy than any psychedelia and with
excessive consumption (usually with beer) people often have slurred
speech and slow/reduced reflexes [. . . ]” (42).
Other species commonly claimed to be capable of producing
hallucinations include several species of sea chub from the
genus Kyphosus, supposed to be K. fuseus or more likely
K. vaigiensis, which may cause “dreadful nightmares” (18).
Furthermore, some Caribbean natives, particularly Mayan
tribes during the pre-Colombian period, were and are usual
consumers of the Urolophus jamaicensis species with their
stingrays’ venom for their entheogen/intoxicant/inebriating and
aphrodisiac properties (23). Moreover, Siganus spinus (aka
“the fish that inebriates”), in the waters around Réunion,
and Mulloides flavolineatus (formerly Mulloidichthys samoensis),
called “the chief of ghosts” in Hawaii, have been consumed due to
their psychedelic properties (24).
Another hallucinogenic fish group is represented by the
Tetraodontidae fish which include puffers, balloon fish, blowfish,
bubble fish, globefish, swellfish, toadfish, and toadies (25).
The name derived by the tetrodotoxin (TTX) that is a
particularly potent neurotoxin, which specifically blocks voltage-
gated sodium channels on the surface of nerve membranes (43).
Its use has been historically documented as a pain-killer, for
rheumatism/arthritis/neurological pain, as aphrodisiac/inebriant
and essential component used during the preparation process
of the “zombie drug” (34). TTX is commonly present in the
gonads, liver, intestines, and skin of pufferfish (43). The first
symptomatology consists in a slight numbness of the lips and
tongue, appearing between 20min to 3 h after eating poisonous
pufferfish. Subsequently, an increasing paresthesia in the face and
extremities, which may be followed by sensations of lightness
or floating, appears. Headache, epigastric pain/nausea/diarrhea
and/or vomiting may occur. Occasionally, some reeling or
difficulty in walking have been described. The second stage
of the intoxication is an increasing paralysis. Many victims
are unable to move; even sitting may be difficult. There is an
increasing respiratory distress, altered speech, dyspnea, cyanosis,
and hypotension. Whilst paralysis increases, convulsions, mental
impairment and cardiac arrhythmia may occur. Although
completely paralyzed, subject may be conscious and completely
lucid until shortly before dying. Death usually occurs within 4
to 6 h, with a known range of about 20min to 8 h (26). Puffer
fish toxins have been described by psychonauts as causing “local
paralysis, apparently, a feeling similar to lidocaine”, “a tingly
feeling on the tongue after eating the meticulously prepared puffer-
fish” and for a few people there is no recreation value and plenty of
risk for overdose” (30). A few online anecdotal reports described
the substance “Zombinol”, a fictional substance, to refer to what
Wade Davis wrote in his book “The Serpent and the Rainbow”
(44) which has been supposed to be TTX, the deadly pufferfish
toxin (45, 46).
An example of fish containing TTX is Takifugu and related
genera (27). Fugu fish is eaten in Japan and is famous for being
deadly if prepared incorrectly. The goal of preparing Fugu is not
to remove the drug, but to reduce its levels in the animal, so it is
enjoyable to the person eating it. It has powerful stimulant and
aphrodisiac effects. The trick in preparing Fugu is to remove just
enough of the organs that contain the nerve toxin TTX. When a
non-lethal dose is consumed, it causes tingling in the lips, fingers,
and toes, and extremities. Whilst after a time (or with a larger
dose), the toxin can cause numbness and anesthesia, paresthesia
along with abdominal pain, nausea, and vomiting until muscle
paralysis and respiratory insufficiency (28).
Another hallucinogenic fish is Somniosus microcephalus. It
contains in its flesh trimethylamine oxidase which is converted
into trimethylamine when eaten (29). After its oral intake,
subjects described the onset of a “shark sick” comprising
diarrhea/vomiting/hallucinations/numbness. Despite it not
always being lethal, it may cause a state of near-death for several
days, while the subject remains conscious (29).
Moreover, as previously discussed by Shulgin and Shulgin
(1997), who wrote about “marine tryptamines” (i.e., 5-Bromo-
DMT and 5,6-dibromo-DMT), there are several sea sponges like
Smenospongia aura, S. echina and Verongula rigida which have
been demonstrated to have some psychedelic activity (30–32).
“Psychedelic” Amphibians
Overall, it has been well documented that amphibian skin
may contain a large range of biological active alkaloids, most
possessing a unique pharmacological and therapeutic profile (31).
Amongst alkaloids identified are: steroidal salamandarines (from
salamanders); batrachotoxins (a potent and selective activator
and ligand for Sodium Channels); histrionicotoxins (potent not-
competitive blockers and ligands for nicotine receptor channels);
epibatidine (with a potent anti-nociceptive activity at nicotinic
receptors); the neotropical poison frogs (dendrobatidae); the
pumiliotoxin (with myo-/cardio-tonic activity) contained
in some anuran genera from Dendrobatidae, Mantellidae,
Bufonidae and Myobatrachidae families; several izidines
(pyrrolizidines, indolizidines, quinolizidines and legmizidines),
pyrrolidinesm piperidines and various tricyclics (related
in structures to the coccinellines), and spiropyrrolizidines,
pseudophrynamine, and the tryptamine bufotenin (47–49).
Furthermore, high levels of amines, including serotonin,
histamine and tyramine, have been found in the skin of various
toads and frogs and synthesized by the amphibian itself due to
their irritant properties on buccal tissue which is used as chemical
defense (50). In addition, high levels of vasoactive peptides such
as bradykinin, sauvagine, physaelaemin, caerulein, bombesin,
dermorphins, etc., have been presumably used as defense against
predators and microorganisms (51).
Amongst the amphibians, Bufo alvarius and Bufo marinus,
morphologically similar, possess prominent parathyroid glands
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that secrete a viscous milky-white venom (52) containing two
cardiac glucosides, namely bufotenin and bufotoxin (33). Some
anthropologists described ancient peoples of Mesoamerica who
used these toads as a ritual intoxicant (7, 53, 54). Furthermore,
it has been assumed to be a specific psychoactive ingredient in
B. Marinus venom, used as “Zombie’s powder”, known during
the pre-Columbian period in North-America (34, 35). Toad
venom may be sometimes found in some Chinese products
used in traditional Chinese medicine, such as “chan su,”
sold as topical aphrodisiacs (aka “stone,” “love stone,” “rock
hard”) (55). B. alvarius, the Sonoran Desert toad, is a semi-
aquatic amphibian found only in the Sonoran Desert, an
area of California across the southern half of Arizona and
South Mexico (36). B. Alvarius contains the enzyme O-methyl-
transferase, which converts bufotenin (5-OH-DMT) to the
potent hallucinogen 5-methoxydimethyl-tryptamine (5-MeO-
DMT) (36). The skin contains some indolealkylamines and
their metabolites belonging to the common series of 5-hydroxy-
indolealkylamines (e.g., bufotenin) and to the less common
series of 5-methoxyindolealkylamines (e.g., O-methyl-bufotenin)
(37, 56, 57). In addition, its skin contains also sulfur-containing
indolealkylamines (e.g., bufoviridine). Consuming Bufo toad
venom orally, through licking or eating, is ineffective and
potentially risky, being associated sometimes with fatalities, as
the venom was evolved to be a defensive poison to deter
predators from eating the toads. Furthermore, many species
of frogs and toads produce other venoms or skin irritants
that should not be ingested orally. Single deep inhalations of
vaporized venom proved powerfully psychoactive effects within
15 s. Consistent with the known effects of 5-MeO-DMT, the
intoxication is intense and short-lived, marked by auditory and
visual hallucinations. The strongest effects dissipated after 5min,
but residual changes in perception persisted for up to 1 h (35, 36).
Another specie is Phillomedusa bicolor, which is a large
green nocturnal frog that lives in the trees of the Peruvian
and Brazilian Amazon. Adult frogs secrete a material which
is used by the native Mayoruna Indians as a hunting aid
(37). Skin secretions are rich in vasoactive, opioid peptides
and a peptide called “adenoregulin” (58). Peptides tested acted
as potent mu opioid agonists on isolated organ preparations
(59). Skin secretions, previously scraped from a live frog
and stored dry on a stick mixed with saliva, for buccal
absorption, may induce a plethora of symptoms including rapid
pulse/incontinence/vomiting, followed by the onset of a state
of listlessness (which may last some days) that proceeds with a
euphoric state (38).
Psychedelic Ants
It has been as well documented that ants have been used
in both curative and preventative medicine, for treating
common illnesses (e.g., paralysis, gastrointestinal illnesses, severe
colds, pain, arthritis, and gynecological disorders), frequently
swallowed live as an emetic or bitten the exterior of the ants’
body (60). Behind the medicine practice, ants seemed to play a
significant role during some initiatory/ritual/esoteric activities.
For example, ants have a prominent role during the antinic or
“ant ordeal” of the Luiseiio, a rite which followed temporally the
ritual of Datura drinking (39). The ingestion of live ants may
cause hallucinogenic and/or mind-altering effects, as described
in discussions on the shamanistic behavior or medical knowledge
of native people (39). Indian people ate harvester ants after 3
days of abstaining from food, water, and sex and avoiding contact
with blood, as a ritualistic hallucinogen (40). They ate balls of
moistened eagle down with about 5 ants inside each (38, 60).
The dose was regulated, from dozens to ninety or so balls, and
the ant feeding stopped when the eyes of the subject turned
red, they became lethargic and refused more (40). To obtain
some shamanistic powers, the ants would be eaten in a similar
manner, every summer, until the powers were obtained (40). Ant
ingestion persisted through the Mission Period (1800–1878), but
these practices appeared to have been abandoned during the last
century (40). However, most studies were confounded by the
simultaneous employment of techniques such as fasting, sleep
deprivation, and the concomitant use of Datura and/or other
psychotropic substances.
However, it has been speculated that the ants used in
vision quests may have belonged to the yellow honey ant or
other species of the Myrmacomecocystus genus, which do not
contain any known psychoactive substances (39). Red harvester
ants (e.g., Pogonomyrmex californicus), largely used in religious
and medical practices, were as well reported to be taken
by native people of Southern and South-central California,
as hallucinogens (40). Their venom contains many kinds of
proteins, enzymes, histamines, and other chemicals. It has been
reported to be 5 and 8–10 times more toxic than, respectively,
Oriental Homet and honeybee venoms (61). The doses employed
in visionary contexts by California Indians were clearly within the
range of pharmacological activity, representing approximately
35% of a lethal dose for an individual with a body weight of
45.5 kg (40). Moreover, it contains formic acid and polypeptide
kinins which induce pain/inflammation/hypotension. Some
kinins own nicotinic cholinergic activity that may be responsible
for the induction of hallucinations (40).
DISCUSSION
The present paper specifically focused on invertebrates and
vertebrates, such as ants, fish, and amphibians and their
possible hallucinogenic properties and their relative and potential
human recreational consumption and/or abuse. Specifically, the
above-mentioned “psychoactive fauna” (17) have been reviewed,
focusing on their first intake according to a historical perspective,
their chemical/pharmacological profile, potential mechanisms
of action and desired/adverse effects. Despite limited literature
and scientific evidence being available to date, as most studies
more specifically focused on psychedelic/hallucinogenic drugs
contained in some plants and plant-derived, a plethora of
data coming from the online platform and psychonauts’ fora
and/or blogs have been collected, according to a nonparticipant
netnographic methodological approach, about the “psychedelic
animals” (15) and subsequently compared with published
literature, following a mini-review approach.
Substances influencing mood and thinking processes have
been known to humanity at least from early Neolithic
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times in all known cultures (8). Entheogens are typically
psychedelics/hallucinogens, and, by definition, imply the use of
psychoactive substances for religious/spiritual reasons (9, 62, 63).
Entheogens generate transcendental feelings or hallucinatory
experiences, which may be enhanced by ritualistic environments
e.g., darkness, chanting, spiritual discourse. Shamans throughout
the world incorporate entheogens in their arsenal of techniques
to connect with the spirit world (64).
Nowadays, many different classes of psychoactive substances
are available for abuse, including several hundred NPS (5, 6, 65).
Some of these drugs are entirely synthetic and others occur
naturally in plants (or in animals), or are chemically modified
from plant or animal compounds (11). Moreover, the current
drug culture, i.e., psychonauts, consume a great variety of
NPS with hallucinogenic/psychedelic properties, including those
contained in some species of animals (3, 15). Specifically, there
is a subcategory of e-psychonauts, as previously studied, who are
particularly interested in taking only “natural” NPS, like plants
and animals (3, 6, 11, 15).
“Psychedelic fauna” appears to be divided in two groups:
the producers and the consumers. Producers represent animal
species able to produce psychoactive chemicals, usually by
converting precursors which they consume, into a new substance
able to be “psychoactive” to humans. Consumers comprise any
animal which takes psychoactive chemicals and store them
unchanged (42). In the present mini-review we focused on
the “producers,” supposed to be taken by the psychonauts’
communities due to their supposed psychedelic/hallucinogenic
properties. Data were collected and summarized for three
main species (i.e., fish, amphibian and ants), even though
the recreational and psychedelic intake of other animals by
psychonauts has been as well documented (30, 34, 42).
Amongst fish, despite the toxic agents implicated remaining
unknown, some authors suggested that their hallucinogenic
properties may derive from alkaloids of the indole group,
dimethyltryptamine (DMT) which naturally occur in certain
types of microalgae (Caulerpaceae family) that fish usually ingest
and phytoplankton and which are probably present in the head
of some fish (18, 19).
The metabolic source of TTX, included in the Tetraodontidae
fish (e.g., puffer-, balloon-, blow-, bubble-, globe-fish, etc.) is
uncertain. No algal source has been identified. TTX was recently
assumed to be a metabolic product of the host. However, recent
reports of the production of TTX/anhydro-TTX by several
bacterial species, including strains of the family Vibrionaceae,
Pseudomonas sp., and Photo bacterium phosphoreum, point
toward a bacterial origin of this family of toxins. These are
relatively common marine bacteria that are often associated with
some marine animals. An association between TTX-producing
bacteria and higher organisms appears to offer clear advantages
to both partners. The bacteria get a safe place to live, eat, and
reproduce; the hosts use the toxin for predation or defense or
both (25, 26, 43).
Whilst amongst amphibians, the tryptamine bufotenin,
isolated in the skin of some species of toads, has been implicated
to determine hallucinogenic effects after the intake of some
amphibians, as abovementioned (47–49, 51). In fact, its name
originates from the Bufo genus of toads that secrete bufotoxins
from their parotid glands (33, 52). Bufotenin is chemically like
the psychedelic psilocin (4-HO-DMT), 5-MeO-DMT, and DMT
(36, 56, 57).
Furthermore, some potentially hallucinogenic and/or mind-
altering substances have been isolated and demonstrated to be
effective from ant toxins (39, 40, 61), even though formally
detected specific substances have not been implicated yet.
In conclusion, the recent re-emergence of a specific
“appealing”/“attractiveness” toward psychedelic/hallucinogenic
substances by psychonauts (3, 5, 15), particularly plant-
derived as previously investigated (11), is gradually opening
to the development and spread of a new “psychedelic
trend,” including “psychedelic fauna” as well. Further
evaluation/isolation/identification of substances potentially
psychedelic/hallucinogenic from some species of animals as well
as further netnographic studies, specifically investigating the
psychonauts’ preferences and interest toward the “psychedelic
fauna” should be carried out, to better understand this new NPS
trend.
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